<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MK-0616 (Enlicitide) - Comprehensive Drug Profile | Leaf Intelligence</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        /* Custom animations matching your style */
        @keyframes fadeInRow {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }
        @keyframes pulse {
            0%, 100% { opacity: 0.5; transform: scale(0.95); }
            50% { opacity: 0.8; transform: scale(1.1); }
        }
        @keyframes slideIn {
            from { opacity: 0; transform: translateX(-10px); }
            to { opacity: 1; transform: translateX(0); }
        }
        .animate-fade-in-row { animation: fadeInRow 0.3s ease forwards; }
        .animate-pulse-glow { animation: pulse 3s ease-in-out infinite; }
        .animate-slide-in { animation: slideIn 0.6s ease-out forwards; }
        
        /* Staggered animations */
        .stagger-1 { animation-delay: 0.1s; }
        .stagger-2 { animation-delay: 0.2s; }
        .stagger-3 { animation-delay: 0.3s; }
        .stagger-4 { animation-delay: 0.4s; }
        
        /* Custom scrollbar */
        ::-webkit-scrollbar { width: 8px; height: 8px; }
        ::-webkit-scrollbar-track { @apply bg-gray-100 dark:bg-gray-800 rounded; }
        ::-webkit-scrollbar-thumb { @apply bg-gray-400 dark:bg-gray-600 rounded hover:bg-gray-500 dark:hover:bg-gray-500; }
        
        /* Glass effect */
        .glass {
            background: rgba(255, 255, 255, 0.75);
            backdrop-filter: blur(20px);
            -webkit-backdrop-filter: blur(20px);
        }
        .dark .glass {
            background: rgba(17, 24, 39, 0.75);
        }
    </style>
</head>
<body class="bg-gray-50 dark:bg-gray-900 transition-all duration-300">
    <!-- Fixed Header - Matching your Leaf Intelligence design -->
    <header class="fixed top-0 left-0 right-0 z-50 glass border-b border-gray-200 dark:border-gray-700 shadow-lg">
        <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
            <div class="flex justify-between items-center py-4">
                <!-- Logo -->
                <div class="flex items-center space-x-3">
                    <div class="relative">
                        <div class="h-12 w-12 bg-gradient-to-r from-green-400 to-cyan-400 rounded-lg flex items-center justify-center">
                            <span class="text-white text-2xl">üçÉ</span>
                        </div>
                        <div class="absolute inset-0 bg-gradient-to-r from-green-400 to-cyan-400 opacity-20 blur-xl animate-pulse-glow"></div>
                    </div>
                    <div>
                        <div class="text-xl font-light bg-gradient-to-r from-green-600 to-cyan-600 dark:from-green-400 dark:to-cyan-400 bg-clip-text text-transparent">
                            Leaf Intelligence
                        </div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 font-light">
                            MK-0616 Drug Profile
                        </div>
                    </div>
                </div>

                <!-- Navigation -->
                <nav class="hidden md:flex items-center space-x-1 bg-gray-100/50 dark:bg-gray-800/50 p-1.5 rounded-lg backdrop-blur-sm">
                    <a href="index.html" class="nav-tab px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white hover:bg-white/50 dark:hover:bg-gray-700/50">
                        Overview
                    </a>
                    <button class="nav-tab px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 bg-white dark:bg-gray-700 text-indigo-600 dark:text-indigo-400 shadow-md active">
                        Drug Profile
                    </button>
                    <a href="index.html#comparison" class="nav-tab px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white hover:bg-white/50 dark:hover:bg-gray-700/50">
                        Comparison
                    </a>
                </nav>

                <!-- Theme Toggle -->
                <button onclick="toggleTheme()" class="relative w-14 h-7 rounded-full bg-gray-200 dark:bg-gray-700 transition-all duration-300 shadow-inner hover:shadow-md">
                    <div class="absolute top-0.5 left-0.5 w-6 h-6 rounded-full bg-white dark:bg-gray-900 shadow-lg transform transition-transform duration-300 dark:translate-x-7 flex items-center justify-center">
                        <svg class="w-4 h-4 text-yellow-500 dark:hidden" fill="currentColor" viewBox="0 0 24 24">
                            <path d="M12 7a5 5 0 100 10 5 5 0 000-10z"/>
                        </svg>
                        <svg class="w-4 h-4 text-indigo-400 hidden dark:block" fill="currentColor" viewBox="0 0 24 24">
                            <path d="M21 12.79A9 9 0 1111.21 3 7 7 0 0021 12.79z"/>
                        </svg>
                    </div>
                </button>
            </div>
        </div>
    </header>

    <!-- Main Container with padding for fixed header -->
    <div class="pt-20 min-h-screen">
        <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8 py-8">
            
            <!-- Hero Section -->
            <div class="glass rounded-2xl p-8 mb-8 border border-gray-200 dark:border-gray-700">
                <div class="flex flex-col md:flex-row justify-between items-start md:items-center gap-4">
                    <div>
                        <h1 class="text-4xl font-light mb-2 text-gray-900 dark:text-white">
                            MK-0616 <span class="text-2xl text-gray-600 dark:text-gray-400">(Enlicitide Decanoate)</span>
                        </h1>
                        <p class="text-lg text-gray-600 dark:text-gray-400">
                            First-in-Class Oral PCSK9 Inhibitor ‚Ä¢ Merck & Co., Inc.
                        </p>
                    </div>
                    <div class="flex flex-wrap gap-2">
                        <span class="inline-flex items-center px-4 py-2 rounded-full text-sm font-medium bg-gradient-to-r from-amber-500 to-orange-500 text-white">
                            Phase 3 Complete
                        </span>
                        <span class="inline-flex items-center px-4 py-2 rounded-full text-sm font-medium bg-gradient-to-r from-green-500 to-emerald-500 text-white">
                            üéØ First Oral PCSK9i
                        </span>
                    </div>
                </div>
            </div>

            <!-- Tab Navigation -->
            <div class="glass rounded-2xl mb-8 border border-gray-200 dark:border-gray-700">
                <div class="flex flex-wrap gap-1 p-2">
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all bg-indigo-600 text-white" onclick="showTab('overview', event)">
                        Overview
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all bg-gray-100 dark:bg-gray-800 text-gray-700 dark:text-gray-300 hover:bg-gray-200 dark:hover:bg-gray-700" onclick="showTab('mechanism', event)">
                        Mechanism
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all bg-gray-100 dark:bg-gray-800 text-gray-700 dark:text-gray-300 hover:bg-gray-200 dark:hover:bg-gray-700" onclick="showTab('clinical', event)">
                        Clinical Data
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all bg-gray-100 dark:bg-gray-800 text-gray-700 dark:text-gray-300 hover:bg-gray-200 dark:hover:bg-gray-700" onclick="showTab('timeline', event)">
                        Timeline
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all bg-gray-100 dark:bg-gray-800 text-gray-700 dark:text-gray-300 hover:bg-gray-200 dark:hover:bg-gray-700" onclick="showTab('safety', event)">
                        Safety
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all bg-gray-100 dark:bg-gray-800 text-gray-700 dark:text-gray-300 hover:bg-gray-200 dark:hover:bg-gray-700" onclick="showTab('commercial', event)">
                        Commercial
                    </button>
                </div>
            </div>

            <!-- Overview Tab -->
            <div class="tab-content active" id="overview">
                <!-- Game Changer Alert -->
                <div class="glass rounded-2xl p-6 mb-8 border border-gray-200 dark:border-gray-700 bg-gradient-to-r from-green-50 to-emerald-50 dark:from-green-900/20 dark:to-emerald-900/20">
                    <h3 class="text-xl font-medium text-gray-900 dark:text-white mb-3">
                        üéØ Game-Changing Innovation
                    </h3>
                    <p class="text-gray-700 dark:text-gray-300 leading-relaxed">
                        First oral PCSK9 inhibitor - No injections required! Daily tablet provides similar efficacy to injectable monoclonal antibodies 
                        (60-65% LDL reduction) with the convenience of oral administration. This could transform PCSK9 inhibition from specialist 
                        injectable therapy to primary care oral treatment.
                    </p>
                    <div class="mt-4">
                        <a href="https://www.merck.com/news/merck-announces-positive-topline-results-from-pivotal-phase-3-trial-evaluating-mk-0616/" 
                           target="_blank" 
                           class="inline-flex items-center text-sm text-indigo-600 dark:text-indigo-400 hover:text-indigo-800 dark:hover:text-indigo-300">
                            View Merck Press Release ‚Üí
                        </a>
                    </div>
                </div>

                <!-- Key Metrics Grid -->
                <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6 mb-8">
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-3xl font-bold bg-gradient-to-r from-indigo-600 to-purple-600 bg-clip-text text-transparent mb-2">
                            60-65%
                        </div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">LDL-C Reduction</div>
                        <div class="text-xs text-gray-500 dark:text-gray-500 mt-1">Comparable to mAbs</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-3xl font-bold bg-gradient-to-r from-green-600 to-emerald-600 bg-clip-text text-transparent mb-2">
                            >80%
                        </div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Achieve <70 mg/dL</div>
                        <div class="text-xs text-gray-500 dark:text-gray-500 mt-1">Guideline goals</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-3xl font-bold bg-gradient-to-r from-amber-600 to-orange-600 bg-clip-text text-transparent mb-2">
                            Daily
                        </div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Oral Dosing</div>
                        <div class="text-xs text-gray-500 dark:text-gray-500 mt-1">Once daily tablet</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-3xl font-bold bg-gradient-to-r from-purple-600 to-pink-600 bg-clip-text text-transparent mb-2">
                            2027
                        </div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Expected Approval</div>
                        <div class="text-xs text-gray-500 dark:text-gray-500 mt-1">FDA submission 2026</div>
                    </div>
                </div>

                <!-- Detailed Info Cards -->
                <div class="grid grid-cols-1 lg:grid-cols-3 gap-8">
                    <div class="glass rounded-2xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="flex items-center gap-2 mb-4 text-lg font-medium text-gray-900 dark:text-white">
                            <span class="w-8 h-8 bg-gradient-to-r from-indigo-600 to-purple-600 rounded-full flex items-center justify-center text-white text-sm">üî¨</span>
                            Key Innovation
                        </h3>
                        <ul class="space-y-3">
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Ä¢</span>
                                Macrocyclic peptide (~1 kDa)
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Ä¢</span>
                                Survives GI degradation via cyclization
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Ä¢</span>
                                >90% PCSK9 suppression
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Ä¢</span>
                                No CYP drug interactions
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Ä¢</span>
                                Once-daily oral dosing
                            </li>
                        </ul>
                        <div class="mt-4 pt-4 border-t border-gray-200 dark:border-gray-700">
                            <a href="https://clinicaltrials.gov/search?cond=Hypercholesterolemia&intr=MK-0616" 
                               target="_blank" 
                               class="text-xs text-indigo-600 dark:text-indigo-400 hover:text-indigo-800">
                                View Clinical Trials ‚Üí
                            </a>
                        </div>
                    </div>

                    <div class="glass rounded-2xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="flex items-center gap-2 mb-4 text-lg font-medium text-gray-900 dark:text-white">
                            <span class="w-8 h-8 bg-gradient-to-r from-green-600 to-emerald-600 rounded-full flex items-center justify-center text-white text-sm">üìä</span>
                            Clinical Performance
                        </h3>
                        <ul class="space-y-3">
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚úì</span>
                                Phase 3 met primary endpoints
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚úì</span>
                                ApoB/non-HDL: 45-55% reduction
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚úì</span>
                                Lp(a): 20-30% reduction
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚úì</span>
                                14,000-patient outcomes trial
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-amber-500 mr-2 mt-1">‚ßó</span>
                                MACE data expected 2029
                            </li>
                        </ul>
                        <div class="mt-4 pt-4 border-t border-gray-200 dark:border-gray-700">
                            <a href="https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/03/03/04/17/coralreef" 
                               target="_blank" 
                               class="text-xs text-indigo-600 dark:text-indigo-400 hover:text-indigo-800">
                                ACC 2023 Data ‚Üí
                            </a>
                        </div>
                    </div>

                    <div class="glass rounded-2xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="flex items-center gap-2 mb-4 text-lg font-medium text-gray-900 dark:text-white">
                            <span class="w-8 h-8 bg-gradient-to-r from-amber-600 to-orange-600 rounded-full flex items-center justify-center text-white text-sm">üéØ</span>
                            Strategic Advantages
                        </h3>
                        <ul class="space-y-3">
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Üí</span>
                                First-mover in oral PCSK9
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Üí</span>
                                Broad GP prescribing
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Üí</span>
                                Pharmacy benefit coverage
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Üí</span>
                                No injection training
                            </li>
                            <li class="text-sm text-gray-600 dark:text-gray-400 flex items-start">
                                <span class="text-green-500 mr-2 mt-1">‚Üí</span>
                                Lower cost potential
                            </li>
                        </ul>
                        <div class="mt-4 pt-4 border-t border-gray-200 dark:border-gray-700">
                            <a href="https://investors.merck.com/events-and-presentations/" 
                               target="_blank" 
                               class="text-xs text-indigo-600 dark:text-indigo-400 hover:text-indigo-800">
                                Investor Presentations ‚Üí
                            </a>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Mechanism Tab -->
            <div class="tab-content hidden" id="mechanism">
                <div class="glass rounded-2xl p-6 mb-8 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-xl font-medium text-gray-900 dark:text-white mb-4">Mechanism of Action</h3>
                    <div class="prose prose-sm max-w-none text-gray-600 dark:text-gray-400">
                        <p class="mb-4">
                            Enlicitide decanoate is a <span class="font-medium text-indigo-600 dark:text-indigo-400">macrocyclic peptide</span> designed as an 
                            <span class="font-medium text-indigo-600 dark:text-indigo-400">oral PCSK9 inhibitor</span>. Key mechanistic features:
                        </p>
                        <ul class="space-y-2 ml-4">
                            <li><strong>Molecular design:</strong> Small cyclic peptide (~1 kDa) engineered for oral bioavailability</li>
                            <li><strong>GI stability:</strong> Survives digestive enzymes through cyclization</li>
                            <li><strong>Target binding:</strong> High-affinity binding to circulating PCSK9</li>
                            <li><strong>Mode of action:</strong> Prevents PCSK9-LDL receptor interaction</li>
                            <li><strong>PCSK9 suppression:</strong> >90% reduction (comparable to mAbs)</li>
                        </ul>
                    </div>
                </div>

                <!-- Dosing Cards -->
                <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6 mb-8">
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-all">
                        <div class="text-2xl font-bold text-gray-900 dark:text-white mb-2">6 mg</div>
                        <div class="text-xl font-medium text-indigo-600 dark:text-indigo-400">41.2%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400 mt-2">LDL-C reduction</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-all">
                        <div class="text-2xl font-bold text-gray-900 dark:text-white mb-2">12 mg</div>
                        <div class="text-xl font-medium text-indigo-600 dark:text-indigo-400">55.7%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400 mt-2">LDL-C reduction</div>
                    </div>
                    <div class="glass rounded-xl p-6 border-2 border-green-500 dark:border-green-400 hover:shadow-lg transition-all bg-gradient-to-r from-green-50 to-emerald-50 dark:from-green-900/20 dark:to-emerald-900/20">
                        <div class="text-2xl font-bold text-gray-900 dark:text-white mb-2">18 mg</div>
                        <div class="text-xl font-medium text-green-600 dark:text-green-400">59.7%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400 mt-2">Near-maximal</div>
                    </div>
                    <div class="glass rounded-xl p-6 border-2 border-green-500 dark:border-green-400 hover:shadow-lg transition-all bg-gradient-to-r from-green-50 to-emerald-50 dark:from-green-900/20 dark:to-emerald-900/20">
                        <div class="text-2xl font-bold text-gray-900 dark:text-white mb-2">30 mg</div>
                        <div class="text-xl font-medium text-green-600 dark:text-green-400">60.9%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400 mt-2">Maximum efficacy</div>
                    </div>
                </div>

                <div class="glass rounded-xl p-4 border-l-4 border-amber-500 bg-amber-50 dark:bg-amber-900/20">
                    <p class="text-sm text-gray-700 dark:text-gray-300">
                        <strong>‚ö†Ô∏è Adherence Consideration:</strong> Real-world adherence to daily medications typically ~50% at 1 year. 
                        Digital adherence tools and patient support programs planned. Compare to inclisiran's guaranteed compliance 
                        via supervised biannual injections.
                    </p>
                </div>
            </div>

            <!-- Clinical Data Tab -->
            <div class="tab-content hidden" id="clinical">
                <div class="glass rounded-2xl overflow-hidden border border-gray-200 dark:border-gray-700 mb-8">
                    <div class="overflow-x-auto">
                        <table class="w-full">
                            <thead class="bg-gray-50 dark:bg-gray-800 border-b border-gray-200 dark:border-gray-700">
                                <tr>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Trial</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Phase</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">N</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Primary Endpoint</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Results</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Status</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Data</th>
                                </tr>
                            </thead>
                            <tbody class="divide-y divide-gray-200 dark:divide-gray-700">
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4 text-sm text-gray-900 dark:text-white">NCT05261126</td>
                                    <td class="px-6 py-4"><span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-purple-100 dark:bg-purple-900/30 text-purple-800 dark:text-purple-400">Phase 2b</span></td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">381</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">% LDL-C at week 8</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">41-61% reduction</td>
                                    <td class="px-6 py-4"><span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">Complete</span></td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/study/NCT05261126" target="_blank" class="text-indigo-600 dark:text-indigo-400 hover:text-indigo-800 text-xs">View ‚Üí</a>
                                    </td>
                                </tr>
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4 text-sm text-gray-900 dark:text-white">CORALreef Lipids</td>
                                    <td class="px-6 py-4"><span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">Phase 3</span></td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">~2,700</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">% LDL-C at week 24</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">>80% achieved <70 mg/dL</td>
                                    <td class="px-6 py-4"><span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">Complete</span></td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/study/NCT05952856" target="_blank" class="text-indigo-600 dark:text-indigo-400 hover:text-indigo-800 text-xs">View ‚Üí</a>
                                    </td>
                                </tr>
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4 text-sm text-gray-900 dark:text-white">CORALreef HeFH</td>
                                    <td class="px-6 py-4"><span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">Phase 3</span></td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">~300</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">% LDL-C at week 24</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">60-65% reduction</td>
                                    <td class="px-6 py-4"><span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">Complete</span></td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/study/NCT05952869" target="_blank" class="text-indigo-600 dark:text-indigo-400 hover:text-indigo-800 text-xs">View ‚Üí</a>
                                    </td>
                                </tr>
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4 text-sm text-gray-900 dark:text-white">CORALreef Outcomes</td>
                                    <td class="px-6 py-4"><span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-amber-100 dark:bg-amber-900/30 text-amber-800 dark:text-amber-400">Phase 3</span></td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">~14,000</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">MACE reduction</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">Pending (2029)</td>
                                    <td class="px-6 py-4"><span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-amber-100 dark:bg-amber-900/30 text-amber-800 dark:text-amber-400">Ongoing</span></td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/study/NCT06008756" target="_blank" class="text-indigo-600 dark:text-indigo-400 hover:text-indigo-800 text-xs">View ‚Üí</a>
                                    </td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>

                <!-- Efficacy Chart -->
                <div class="glass rounded-2xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-medium text-gray-900 dark:text-white mb-6">Secondary Endpoints Achievement</h3>
                    <div class="grid grid-cols-2 md:grid-cols-4 gap-6">
                        <div class="text-center">
                            <div class="text-2xl font-bold text-gray-900 dark:text-white">45-55%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400 mt-1">ApoB Reduction</div>
                        </div>
                        <div class="text-center">
                            <div class="text-2xl font-bold text-gray-900 dark:text-white">45-55%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400 mt-1">Non-HDL-C</div>
                        </div>
                        <div class="text-center">
                            <div class="text-2xl font-bold text-amber-600 dark:text-amber-400">20-30%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400 mt-1">Lp(a)</div>
                        </div>
                        <div class="text-center">
                            <div class="text-2xl font-bold text-green-600 dark:text-green-400">>90%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400 mt-1">PCSK9 Suppression</div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Timeline Tab -->
            <div class="tab-content hidden" id="timeline">
                <div class="glass rounded-2xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-xl font-medium text-gray-900 dark:text-white mb-6">Development Timeline</h3>
                    
                    <div class="relative pl-8">
                        <!-- Timeline line -->
                        <div class="absolute left-3 top-0 bottom-0 w-0.5 bg-gradient-to-b from-transparent via-indigo-300 dark:via-indigo-600 to-transparent"></div>
                        
                        <!-- Timeline items -->
                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-indigo-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-indigo-600 dark:text-indigo-400 mb-1">NOVEMBER 2021</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">Phase 1 Results</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    First human data showed >90% PCSK9 reduction, LDL-C drops up to 65%
                                </div>
                                <a href="https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10774" target="_blank" class="text-xs text-indigo-600 dark:text-indigo-400 mt-2 inline-block">
                                    AHA 2021 Abstract ‚Üí
                                </a>
                            </div>
                        </div>

                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-indigo-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-indigo-600 dark:text-indigo-400 mb-1">MARCH 6, 2023</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">Phase 2b Results</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    381 patients, 41-61% LDL reduction dose-dependent
                                </div>
                                <a href="https://www.acc.org/Latest-in-Cardiology/Articles/2023/03/05/19/49/mon-1045am-mk-0616-acc-2023" target="_blank" class="text-xs text-indigo-600 dark:text-indigo-400 mt-2 inline-block">
                                    ACC 2023 Presentation ‚Üí
                                </a>
                            </div>
                        </div>

                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-green-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-green-600 dark:text-green-400 mb-1">JUNE 9, 2025</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">‚úÖ Positive Phase 3 Results</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    CORALreef trials met primary endpoints. 60-65% LDL reduction confirmed
                                </div>
                                <a href="https://www.merck.com/news/" target="_blank" class="text-xs text-indigo-600 dark:text-indigo-400 mt-2 inline-block">
                                    Press Release ‚Üí
                                </a>
                            </div>
                        </div>

                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-amber-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-amber-50 dark:bg-amber-900/20 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-amber-600 dark:text-amber-400 mb-1">MID-2026 (PROJECTED)</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">NDA Filing</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    FDA submission expected with priority review possible
                                </div>
                            </div>
                        </div>

                        <div class="relative">
                            <div class="absolute -left-5 w-4 h-4 bg-amber-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-amber-50 dark:bg-amber-900/20 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-amber-600 dark:text-amber-400 mb-1">2027 (PROJECTED)</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">FDA Approval</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    First oral PCSK9 inhibitor launch expected
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Safety Tab -->
            <div class="tab-content hidden" id="safety">
                <div class="glass rounded-2xl p-6 mb-8 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-xl font-medium text-gray-900 dark:text-white mb-4">Safety Overview</h3>
                    <p class="text-gray-600 dark:text-gray-400 mb-6">
                        ~4,000 patients exposed by 2025 with placebo-like safety profile. No black-box warnings anticipated. 
                        Acts extracellularly without CYP metabolism, minimizing drug interactions.
                    </p>
                    
                    <div class="grid grid-cols-2 md:grid-cols-4 gap-6">
                        <div class="text-center p-4 bg-white dark:bg-gray-800 rounded-lg">
                            <div class="text-2xl font-bold text-green-600 dark:text-green-400">6-8%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400">Headache</div>
                        </div>
                        <div class="text-center p-4 bg-white dark:bg-gray-800 rounded-lg">
                            <div class="text-2xl font-bold text-green-600 dark:text-green-400">5-7%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400">Nasopharyngitis</div>
                        </div>
                        <div class="text-center p-4 bg-white dark:bg-gray-800 rounded-lg">
                            <div class="text-2xl font-bold text-green-600 dark:text-green-400"><2%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400">Serious AEs</div>
                        </div>
                        <div class="text-center p-4 bg-white dark:bg-gray-800 rounded-lg">
                            <div class="text-2xl font-bold text-green-600 dark:text-green-400">0%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400">ISR (oral)</div>
                        </div>
                    </div>
                </div>

                <div class="grid grid-cols-1 lg:grid-cols-2 gap-8">
                    <div class="glass rounded-2xl p-6 border border-gray-200 dark:border-gray-700">
                        <h4 class="font-medium text-gray-900 dark:text-white mb-4">‚úì No Safety Signals</h4>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li>‚Ä¢ No liver enzyme elevations</li>
                            <li>‚Ä¢ No CK elevations</li>
                            <li>‚Ä¢ No glucose/diabetes signal</li>
                            <li>‚Ä¢ No blood pressure effects</li>
                            <li>‚Ä¢ No immunogenicity concerns</li>
                        </ul>
                    </div>
                    <div class="glass rounded-2xl p-6 border border-gray-200 dark:border-gray-700">
                        <h4 class="font-medium text-gray-900 dark:text-white mb-4">üíä Safety Advantages</h4>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li>‚Ä¢ No injection site reactions</li>
                            <li>‚Ä¢ Good GI tolerability</li>
                            <li>‚Ä¢ No CYP interactions</li>
                            <li>‚Ä¢ Acts extracellularly only</li>
                            <li>‚Ä¢ Low immunogenicity (<1%)</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Commercial Tab -->
            <div class="tab-content hidden" id="commercial">
                <div class="glass rounded-2xl p-8 mb-8 border border-gray-200 dark:border-gray-700 text-center">
                    <div class="text-4xl font-bold bg-gradient-to-r from-indigo-600 to-purple-600 bg-clip-text text-transparent mb-2">
                        $4,000 - $6,000
                    </div>
                    <div class="text-gray-600 dark:text-gray-400">Projected annual cost (vs $5,800 for injectable mAbs)</div>
                </div>

                <div class="grid grid-cols-2 md:grid-cols-4 gap-6 mb-8">
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">$2-8B</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Market by 2032</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-2xl font-bold text-amber-600 dark:text-amber-400">~50%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Expected adherence</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-2xl font-bold text-red-600 dark:text-red-400">80%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Initial PA denial</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-2xl font-bold text-green-600 dark:text-green-400">10x</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Broader prescribers</div>
                    </div>
                </div>

                <div class="glass rounded-2xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-medium text-gray-900 dark:text-white mb-4">Market Strategy</h3>
                    <div class="prose prose-sm max-w-none text-gray-600 dark:text-gray-400">
                        <p>
                            MK-0616 could transform PCSK9 inhibition from specialist injectable to primary care oral therapy. 
                            Success depends on competitive pricing, managing adherence challenges, and demonstrating CV outcomes by 2029. 
                            Merck's history with blockbuster CV drugs (Zetia, Vytorin) and large Phase 3 program indicate 
                            commitment to broad market penetration.
                        </p>
                    </div>
                    <div class="mt-4 pt-4 border-t border-gray-200 dark:border-gray-700">
                        <a href="https://www.merck.com/research-and-products/cardiovascular/" target="_blank" class="text-sm text-indigo-600 dark:text-indigo-400 hover:text-indigo-800">
                            View Merck CV Portfolio ‚Üí
                        </a>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- JavaScript -->
    <script>
        function toggleTheme() {
            document.body.classList.toggle('dark');
            localStorage.setItem('theme', document.body.classList.contains('dark') ? 'dark' : 'light');
        }

        // Load saved theme
        if (localStorage.getItem('theme') === 'dark' || (!localStorage.getItem('theme') && window.matchMedia('(prefers-color-scheme: dark)').matches)) {
            document.body.classList.add('dark');
        }

        function showTab(tabName, event) {
            // Hide all tabs
            const tabs = document.querySelectorAll('.tab-content');
            tabs.forEach(tab => {
                tab.classList.add('hidden');
                tab.classList.remove('active');
            });
            
            // Update button styles
            const buttons = document.querySelectorAll('.tab-btn');
            buttons.forEach(btn => {
                btn.classList.remove('bg-indigo-600', 'text-white');
                btn.classList.add('bg-gray-100', 'dark:bg-gray-800', 'text-gray-700', 'dark:text-gray-300');
            });
            
            // Show selected tab
            document.getElementById(tabName).classList.remove('hidden');
            document.getElementById(tabName).classList.add('active');
            
            // Style active button
            event.target.classList.remove('bg-gray-100', 'dark:bg-gray-800', 'text-gray-700', 'dark:text-gray-300');
            event.target.classList.add('bg-indigo-600', 'text-white');
        }
    </script>
</body>
</html>